A 2020 Industry Overview on U.S. Banking
December 11, 2019 Financial Services Private Equity M&A
Al Dominick speaks with Tom Michaud, President and CEO of Keefe, Bruyette & Woods, about emerging financial trends to get a fresh perspective on the state of banking in the United States.
Two-Thirds of Corporate Leaders Likely to Acquire in 2020, Survey Shows
December 18, 2019 All Industries M&A
The results of the 2019 Corporate M&A Survey, sponsored by Crowe LLP, examine acquisition strategies and barriers for corporate leadership teams.
How Not to Destroy a Deal
January 7, 2020 All Industries M&A
Kison Patel, the CEO of software company DealRoom, remembers working for a private equity firm trying to do a deal not long ago. His firm bombarded the target company with requests for information — including repetitive requests for the same information, often in Excel spreadsheets. Eventually, the seller got fed up and walked away.
Mega Mergers Get Popular, But Sometimes Fail
January 7, 2020 All Industries M&A
Call it the age of the mega merger. Across industries, some of the biggest companies are joining hands and creating even bigger companies.
Not So Fast: Antitrust Fervor
January 7, 2020 All Industries M&A
Large corporations are under attack from every corner. A group of states are fighting the proposed acquisition of Sprint Corp. by T-Mobile US. The Department of Justice and the Federal Trade Commission are investigating tech giants including Facebook and Alphabet’s Google for antitrust violations. Democratic presidential candidate Elizabeth Warren is proposing breaking up the big tech companies.
Upcoming Event
Transactions 2020 | Health
June 3, 2020 New York New York
Be it a strategic merger or financial acquisition, the healthcare industry has experienced record-setting deal volume over the last few years. Given transactions within the pharma and biotech space to disruptions in healthcare services, we continue to see financial sponsors seeking out new paths to grow. While some believe the pace of consolidation will increase, others wonder if pricing has become too expensive and appetites for deals, overly exuberant. So is now the time to buy, sell or go public? At DirectorCorps’ annual Transactions Conference, we explore these potential paths with top executives and members of the boards of leading healthcare organizations.